Literature DB >> 6972278

Persistent purulent otitis media.

R H Schwartz, W J Rodriguez, W N Khan.   

Abstract

Of 429 children with acute otitis media who returned for follow-up evaluation, 49 (11%) were unresponsive to a 10- to 14-day course of ampicillin, amoxicillin, or erythromycin/sulfisoxazole. Patients with persistent purulent otitis media were noted to have immobile, bulging, yellow or grey, abscessed tympanic membranes at the follow-up visit. A myringotomy was performed on 45 children. Cultures of middle-ear exudate yielded ampicillin-resistant Haemophilus influenzae in 14 (31%), ampicillin-susceptible pathogens (H. influenzae or Streptococcus pneumoniae) in 23 (51%), and no growth in 8 (18%).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972278     DOI: 10.1177/000992288102000703

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  5 in total

Review 1.  Management of acute otitis media in the 1990s: the decade of resistant pneumococcus.

Authors:  S L Block
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

2.  The use of tympanocentesis in the diagnosis and management of acute otitis media.

Authors:  Michael E Pichichero; Tracy Wright
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

3.  In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin.

Authors:  M M Tarpay; D F Welch; H Salari; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

4.  Relationship with original pathogen in recurrence of acute otitis media after completion of amoxicillin/clavulanate: bacterial relapse or new pathogen.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

5.  Non typable-Haemophilus influenzae biofilm formation and acute otitis media.

Authors:  Assaf Mizrahi; Robert Cohen; Emmanuelle Varon; Stephane Bonacorsi; Stephane Bechet; Claire Poyart; Corinne Levy; Josette Raymond
Journal:  BMC Infect Dis       Date:  2014-07-19       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.